Dynatronics (DYNT) AI Stock Analysis

• Market Cap: $790.88K
• Dividend Yield: N/A
• Average Volume (3M): 9.46K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.74
• Revenue Growth: -12.89%
• EPS Growth: -64.68%
• Country: US
• Employees: 111
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.56
• Shares Outstanding: 16,048,735
• 10 Day Avg. Volume: 9,367
• 30 Day Avg. Volume: 9,464
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.21
• Price to Sales (P/S): 0.02
• P/FCF Ratio: 2.48
• Enterprise Value/Market Cap: 8.84
• Enterprise Value/Revenue: 0.26
• Enterprise Value/Gross Profit: 1.21
• Enterprise Value/Ebitda: -0.75
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $0.05 ▲(2.00% Upside)

Dynatronics' overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues, negative profitability, and high leverage. The technical analysis also indicates a bearish trend, further weighing down the score. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, reflecting the company's ongoing financial struggles.

Positive Factors

Recurring Revenue Stream

Recurring revenue from consumables provides a steady income stream, enhancing financial stability and predictability over time.

Market Focus

A focus on innovation and quality in the healthcare sector positions Dynatronics to meet evolving industry needs and maintain competitive advantage.

Partnership Opportunities

Partnerships can enhance market reach and drive sales growth, supporting long-term business expansion and revenue diversification.

Negative Factors

Declining Revenue

Continued revenue decline suggests challenges in market competitiveness and product demand, impacting long-term growth prospects.

High Leverage

High leverage increases financial risk and limits flexibility, potentially affecting the company's ability to invest in growth opportunities.

Negative Profitability

Negative profitability indicates cost management issues and market challenges, which could hinder long-term financial health and shareholder value.

Dynatronics Business Overview & Revenue Model

Company Description

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

How the Company Makes Money

Dynatronics generates revenue through the sale of its medical devices and therapeutic products. The company's revenue model is primarily based on direct sales to healthcare providers, including hospitals, clinics, and rehabilitation centers. Key revenue streams include the sale of physical therapy equipment, rehabilitation modalities, and disposable medical supplies. Additionally, Dynatronics may engage in partnerships with healthcare organizations and distributors, which can enhance its market reach and contribute to sales growth. The company also benefits from recurring revenue through consumable products that require regular replenishment, thereby creating a steady income stream over time.

Dynatronics Financial Statement Overview

Summary

Dynatronics is facing significant financial challenges, with declining revenues, negative profitability, and high leverage. The company's cash flow situation is also concerning, indicating potential liquidity issues. These factors suggest a need for strategic adjustments to improve financial stability and performance.

Income Statement

Dynatronics has experienced declining revenue over the past few years, with a negative revenue growth rate of -2.11% in the TTM. The company is facing significant profitability challenges, as evidenced by negative net profit margins and EBIT margins. The gross profit margin has also decreased slightly over time, indicating pressure on cost management.

Balance Sheet

The balance sheet shows a high debt-to-equity ratio of 2.26 in the TTM, indicating significant leverage and potential financial risk. Return on equity is negative, reflecting ongoing losses. The equity ratio has decreased, suggesting a weakening financial position.

Cash Flow

Cash flow analysis reveals a concerning trend with negative free cash flow growth and low operating cash flow coverage ratio. The free cash flow to net income ratio is positive, but overall cash generation remains weak, highlighting liquidity challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	26.81M	27.39M	32.53M	40.61M	44.34M	47.80M
Gross Profit	5.76M	6.01M	7.63M	10.15M	10.67M	12.89M
EBITDA	-9.31M	-9.37M	-976.01K	-3.50M	-2.42M	3.81M
Net Income	-10.74M	-10.90M	-2.70M	-5.66M	-4.73M	1.21M
Balance Sheet
Total Assets	15.00M	15.44M	25.94M	30.06M	35.43M	39.14M
Cash, Cash Equivalents and Short-Term Investments	761.75K	326.34K	483.92K	398.80K	550.11K	6.10M
Total Debt	6.90M	6.63M	6.69M	5.65M	3.84M	5.08M
Total Liabilities	11.94M	12.18M	11.78M	13.21M	13.73M	13.63M
Stockholders Equity	3.06M	3.26M	14.16M	16.86M	21.70M	25.51M
Cash Flow
Free Cash Flow	75.88K	270.13K	-1.85M	185.15K	-5.20M	236.13K
Operating Cash Flow	106.62K	300.58K	-1.61M	372.00K	-4.88M	383.00K
Investing Cash Flow	-30.74K	-30.45K	-243.29K	-187.00K	-319.00K	1.53M
Financing Cash Flow	407.43K	-427.71K	1.84M	-332.71K	-350.00K	2.02M

Dynatronics Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.05
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DYNT, the sentiment is Positive. The current price of 0.05 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.05, and below the 200-day MA of 0.08, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.81 is Neutral, neither overbought nor oversold. The STOCH value of 37.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DYNT.

Dynatronics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NUWE	48 Neutral	$3.57M	-0.02	-467.14%	―	-8.93%	97.80%
VTAK	43 Neutral	$3.10M	-0.04	-173.74%	―	82.96%	82.04%
DYNT	41 Neutral	$790.88K	-0.04	-125.14%	―	-12.89%	-64.68%
DHAI	37 Underperform	$2.09K	>-0.01	―	―	―	―
BJDX	29 Underperform	$1.39M	-0.02	-126.20%	―	―	97.70%

Dynatronics Corporate Events

Dynatronics Delays Form 10-Q Filing

Dynatronics Corporation has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The delay is attributed to an unforeseen processing issue encountered during the final stages of preparing the financial statements. Despite efforts to mitigate potential obstacles, the issue could not be resolved before the original deadline. The company expects to file the report within the five-calendar-day extension period allowed under Rule 12b-25. Importantly, Dynatronics does not anticipate any material changes to its previously reported financial results due to this delay. The company remains committed to maintaining the accuracy and integrity of its public disclosures. The notification was signed by Brian Baker, the Chief Executive Officer and Chief Financial Officer, on November 17, 2025.

Dynatronics Delays Annual Report Filing

Dynatronics Corporation has announced a delay in filing its Form 10-K (Yearly Report) for the fiscal year ending June 30, 2025. The primary reason for this delay is the additional time required to complete an impairment analysis essential for finalizing the financial statements and related disclosures. The company expects to file the report within the extension period allowed under Rule 12b-25, which is within fifteen calendar days following the original due date. Importantly, Dynatronics does not anticipate any significant changes in its financial results compared to the previous fiscal year. The company remains committed to compliance and transparency, with the notification signed by Brian Baker, the Chief Executive Officer and Chief Financial Officer.